Stoke Therapeutics, Inc. · NASDAQ:STOK
BlackRock Portfolio Management LLC's stake in Stoke Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 15, 2025
BlackRock Portfolio Management LLC's stake in Stoke Therapeutics, Inc. fell to 4.70%, 2,550,341 shares, as a passive investor on Jun 30, 2025. Filed Jul 15, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 2,550,341
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 4.70% | 2,550,341 |
Source
Related
- Stoke Therapeutics, Inc.
- BlackRock Portfolio Management LLC
- Stoke Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock Portfolio Management LLC · Apr 15, 2025
- Form 4 · Allan Jonathan · Oct 2, 2026
- Form 4 · Ticho Barry · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026